deltatrials
Completed PHASE2 NCT00260416

Primary Angioplasty for Acute Myocardial Infarction in Patients With Symptom Duration Above 12 Hours

Sponsor: Aarhus University Hospital Skejby

Conditions Acute Myocardial Infarction
Interventions Primary angioplasty with stent and abciximab
Updated 5 times since 2017 Last updated: May 21, 2008 Started: May 31, 2005 Primary completion: Dec 31, 2007 Completion: Dec 31, 2007

A PHASE2 clinical study on Acute Myocardial Infarction, this trial is completed. The trial is conducted by Aarhus University Hospital Skejby and has accumulated 5 data snapshots since 2005. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Aarhus University Hospital Skejby
  • Danish Heart Foundation
Data source: Aarhus University Hospital Skejby

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Aarhus, Denmark